Stocks and Investing Stocks and Investing
Fri, November 20, 2020
[ 12:00 AM ] - WOPRAI
Richard Hill Upgraded (UDR) to Buy and Held Target at $44 on, Nov 20th, 2020
[ 12:00 AM ] - WOPRAI
Brad Erickson Maintained (UBER) at Strong Buy with Increased Target to $60 on, Nov 20th, 2020
Thu, November 19, 2020
[ 12:00 AM ] - WOPRAI
Catherine Mealor Downgraded (UBSI) to Hold and Held Target at $32 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Daniel Ives Maintained (UBER) at Buy with Increased Target to $60 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Shweta Khajuria Maintained (YELP) at Buy with Increased Target to $34 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Thomas Allen Maintained (WYNN) at Buy with Increased Target to $120 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Christopher York Initiated (TPVG) at Buy and Held Target at $13 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Rohit Seth Upgraded (TOL) to Strong Buy and Increased Target to $60 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Kate Fitzsimons Maintained (TJX) at Buy with Increased Target to $70 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Kimberly Greenberger Maintained (TJX) at Buy with Increased Target to $70 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Laura Champine Maintained (TJX) at Strong Buy with Increased Target to $75 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Michael Binetti Maintained (TJX) at Buy with Increased Target to $72 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Paul Lejuez Maintained (TJX) at Strong Buy with Increased Target to $73 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Mark Altschwager Maintained (TJX) at Buy with Increased Target to $70 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Bill Kirk Upgraded (TGT) to Hold and Held Target at $156 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Matthew McClintock Maintained (TGT) at Strong Buy with Increased Target to $200 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Simeon Gutman Maintained (TGT) at Hold with Increased Target to $180 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Michael Baker Maintained (TGT) at Strong Buy with Increased Target to $208 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Karen Short Maintained (TGT) at Hold with Increased Target to $185 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Mark Astrachan Maintained (TGT) at Hold with Increased Target to $175 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Michael Lasser Maintained (TGT) at Hold with Increased Target to $175 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Robert Ohmes Maintained (TGT) at Strong Buy with Increased Target to $208 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Paul Lejuez Maintained (TGT) at Strong Buy with Increased Target to $200 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
James Faucette Maintained (TTEC) at Hold with Increased Target to $62 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Noelle Dilts Upgraded (AZZ) to Strong Buy and Held Target at $50 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Charles Minervino Maintained (BA) at Buy with Increased Target to $275 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Spiro Dounis Maintained (WES) at Hold with Increased Target to $14 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Richard Close Maintained (AHCO) at Strong Buy with Increased Target to $36 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Joseph Stringer Initiated (APLS) at Strong Buy and Held Target at $59 on, Nov 19th, 2020
[ 12:00 AM ] - WOPRAI
Shawn Egan Initiated (ARWR) at Strong Buy and Held Target at $90 on, Nov 19th, 2020

Shawn Egan Initiated (ARWR) at Strong Buy and Held Target at $90 on, Nov 19th, 2020


Published on 2024-10-27 14:49:44 - WOPRAI, Shawn Egan
  Print publication without navigation


Shawn Egan of Citigroup, Initiated "Arrowhead Pharmaceuticals, Inc." (ARWR) at Strong Buy and Held Target at $90 on, Nov 19th, 2020.

Shawn has made no other calls on ARWR in the last 4 months.



There is 1 other peer that has a rating on ARWR. Out of the 1 peers that are also analyzing ARWR, all agrees with Shawn's Rating of Hold. Following is the relevant analyst calls for the last 4 months

  • Mani Foroohar of "SVB Leerink" Maintained at Hold with Increased Target to $31 on, Thursday, September 17th, 2020
Contributing Sources